Cite

HARVARD Citation

    Sakata, S. et al. (2021). Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy. Thoracic cancer. 12 (3), pp. 397-401. [Online]. 
  
Back to record